Development of Light‐Activated LXR Agonists

Abstract: Activation of the oxysterol‐sensing transcription factor liver X receptor (LXR) has been studied as a therapeutic strategy in metabolic diseases and cancer but is compromised by the side effects of LXR agonists. Local LXR activation in cancer treatment may offer an opportunity to overcome this issue suggesting potential uses of photopharmacology. We report the computer‐aided development of photoswitchable LXR agonists based on the T0901317 scaffold, which is a known LXR agonist. Azologization and structure‐guided structure‐activity relationship evaluation enabled the design of an LXR agonist, which activated LXR with low micromolar potency in its light‐induced (Z)‐state and was inactive as (E)‐isomer. This tool sensitized human lung cancer cells to chemotherapeutic treatment in a light‐dependent manner supporting potential of locally activated LXR agonists as adjuvant cancer treatment.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Development of Light‐Activated LXR Agonists ; day:01 ; month:06 ; year:2023 ; extent:10
ChemMedChem ; (01.06.2023) (gesamt 10)

Urheber
Mukhopadhyay, Tufan K.
Willems, Sabine
Arp, Christopher J.
Morstein, Johannes
Haake, Caleb T.
Merk, Daniel
Trauner, Dirk

DOI
10.1002/cmdc.202200647
URN
urn:nbn:de:101:1-2023060115453202516547
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:01 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Mukhopadhyay, Tufan K.
  • Willems, Sabine
  • Arp, Christopher J.
  • Morstein, Johannes
  • Haake, Caleb T.
  • Merk, Daniel
  • Trauner, Dirk

Ähnliche Objekte (12)